Chemours: Can Titanium Dioxide Pricing Really Carry What Refrigerants Just Lost

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Chemours reports after market close, meaning Day 0 reflects anticipation before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

The historical price action around Chemours earnings reveals dramatic volatility, particularly on the day following the release. Over the past eight quarters, the stock has averaged an absolute move of 4.54% on Day 0 and 9.64% on Day +1, with Day +1 ranges averaging 10.54%. The most striking pattern is the severity of recent post-earnings declines: the last three reports in August, May, and February 2026 all produced Day +1 drops of 18.63%, 15.28%, and 16.51% respectively, far exceeding the historical average. These moves reflect the market's harsh judgment on the company's guidance cuts and deteriorating refrigerant business. The November 2025 report stands as an outlier with a 6.56% Day +1 gain, but that was before the full extent of the aftermarket weakness became clear. Investors should expect significant volatility following this release, with recent history suggesting the market will punish any signs of further deterioration while potentially rewarding evidence that the reset guidance is holding.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 10.11% through the November 6 expiration, which sits above the historical Day 0 average of 4.54% but roughly in line with the 9.64% average Day +1 move. Given that the last three earnings reports produced Day +1 declines of 15% to 19%, the options market appears to be pricing in significant risk while not fully reflecting the extreme downside seen in recent quarters.

Part 3: What Analysts Are Saying

Analyst sentiment toward Chemours has deteriorated significantly heading into this earnings release. The current consensus stands at 3.36 on the five-point scale with an average price target of $16.27, implying roughly 20% upside from the current price of $13.53. However, that upside potential has narrowed as the stock has fallen and analyst confidence has waned.

The rating breakdown shows a divided Street: 2 Strong Buys, 0 Moderate Buys, 9 Holds, 0 Moderate Sells, and 0 Strong Sells across 11 analysts. Just one month ago, the picture was more constructive with 3 Strong Buys, 1 Moderate Buy, and 6 Holds. The shift from 4 buy-rated analysts to just 2, combined with the expansion of hold ratings from 6 to 9, reflects growing caution about the company's near-term prospects. The average recommendation has deteriorated from 3.70 to 3.36 over the past month, a meaningful decline that signals analysts are stepping back from bullish calls.

Price targets range from a low of $14.00 to a high of $20.00, a relatively tight band that suggests limited conviction in either direction. The mean target of $16.27 sits well below the stock's 200-day moving average of $18.40, indicating that even the analyst community has reset expectations lower following the guidance cuts and refrigerant market weakness. With sentiment having deteriorated and the hold camp now dominant, the Street appears to be in wait-and-see mode, looking for evidence that the business has stabilized before recommending aggressive positioning.

Part 4: Technical Picture

Chemours enters this earnings report with a deeply bearish technical setup that reflects the stock's sharp decline since the last quarterly release. The Barchart Technical Opinion currently shows an 88% Sell signal, a slight improvement from the 100% Sell readings seen both last week and last month, but still firmly in bearish territory.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum remains negative, though less extreme than the medium and long-term readings
• Medium-term (100% Sell): Strong sell signal reflects sustained weakness in the intermediate timeframe with no signs of stabilization
• Long-term (100% Sell): Strong sell signal confirms the longer-term trend has turned decisively negative

Trend Characteristics: The signal strength is rated as "Good" but the direction is "Weakening," suggesting the bearish trend remains intact but may be losing some downside momentum as the stock approaches oversold levels.

The moving average structure tells a clear story of deterioration. At $13.53, the stock trades above its 5-day ($13.26), 10-day ($13.07), and 20-day ($13.26) moving averages, showing some very short-term stabilization. However, it remains below all longer-term averages: the 50-day at $14.23, the 100-day at $16.20, and the 200-day at $18.40. The stock is trading more than 26% below its 200-day moving average, a level that typically indicates severe technical damage and suggests a prolonged recovery period even if fundamentals improve.

The key technical level to watch is the $12.49 post-earnings low from August, which sits just below the current price and represents the most recent test of investor capitulation. A break below that level on this earnings release would signal that the selling pressure has not been exhausted. On the upside, the 50-day moving average at $14.23 represents the first meaningful resistance level, though reclaiming that would require a significant fundamental catalyst. The overall technical setup is decidedly cautionary heading into earnings, with the stock deeply oversold but showing no signs of a sustainable reversal. The bearish trend structure suggests that any rally will face heavy resistance at each moving average level, while further disappointment could easily push the stock to new lows.